Colgate-Palmolive grants 55K options to CFO
Colgate-Palmolive’s CFO received new option and RSU awards, increasing his direct and 401(k) share holdings.
Rhea-AI Filing Summary
COLGATE PALMOLIVE CO (symbol: CL) is the issuer of record for a Form 4 filing submitted to the SEC. SUTULA STANLEY J III reported acquisition or exercise transactions in this Form 4 filing.
COLGATE PALMOLIVE CO (CL) reported that Chief Financial Officer Stanley J. Sutula III received new equity awards on September 16, 2026. He was granted 55,674 stock options to buy common shares at $87.02 per share, expiring September 16, 2036, and 8,045 restricted stock units that vest in three equal annual installments. Following these awards, he holds 79,029 common shares directly and 331 shares indirectly through the issuer’s 401(k) plan. No Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 63,719 shares
Grant/Award
3 txns
Insider
SUTULA STANLEY J III
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2, F3 | 55,674 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 8,045 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 55,674 contracts (Direct);
Common Stock — 79,029 shares (Direct);
Common Stock — 331 shares (Indirect, By Issuer's 401(k) Plan Trustee)
Footnotes (3)
- F1. Restricted stock unit award granted under the issuer's incentive compensation plan. The restricted stock unit award vests in equal 1/3 installments on each of the first, second and third anniversary of the date of grant.
- F2. Stock option award granted under the issuer's incentive compensation plan.
- F3. Option becomes exercisable in one-third increments beginning on the first anniversary of the September 16, 2026 grant date.
Key Figures
Stock options granted: 55,674 options
Option exercise price: $87.02 per share
Option expiration: September 16, 2036
+3 more
6 metrics
Stock options granted
55,674 options
Granted to the CFO on September 16, 2026
Option exercise price
$87.02 per share
Exercise price for 55,674 options granted September 16, 2026
Option expiration
September 16, 2036
Expiration date of the 55,674 stock options
Restricted stock units granted
8,045 RSUs
Granted to the CFO on September 16, 2026, vesting over three years
Direct common shares after awards
79,029 shares
CFO’s direct common stock holdings following the September 16, 2026 grants
Indirect 401(k) holdings
331 shares
Common shares held for the CFO by the issuer’s 401(k) plan trustee
Key Terms
restricted stock unit, stock option, incentive compensation plan
3 terms
restricted stock unit financial
"Restricted stock unit award granted under the issuer's incentive compensation plan."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
stock option financial
"Stock option award granted under the issuer's incentive compensation plan."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
incentive compensation plan financial
"Award granted under the issuer's incentive compensation plan."
An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Colgate-Palmolive (CL) grant to its CFO on September 16, 2026?
The CFO received 55,674 stock options to buy common shares at $87.02 per share, expiring September 16, 2036, and 8,045 restricted stock units that vest in three equal annual installments.
How do the new Colgate-Palmolive (CL) restricted stock units vest for the CFO?
The 8,045 restricted stock units granted to the CFO vest in three equal one-third installments on each of the first, second, and third anniversaries of the September 16, 2026 grant date.
When do the new Colgate-Palmolive (CL) stock options become exercisable for the CFO?
The 55,674 stock options become exercisable in one-third increments, beginning on the first anniversary of the September 16, 2026 grant date, and expire on September 16, 2036.
Were the Colgate-Palmolive (CL) CFO’s September 2026 equity awards granted under a plan?
Yes. Both the stock option award and the restricted stock unit award were granted under Colgate-Palmolive’s incentive compensation plan, according to the filing footnotes.
Were the Colgate-Palmolive (CL) CFO’s September 16, 2026 transactions under a Rule 10b5-1 plan?
No. The filing indicates no Rule 10b5-1 trading plan applies to the reported September 16, 2026 equity awards.
AI-generated analysis. How Rhea-AI works. Not financial advice.
